Among patients with psoriatic arthritis (PsA), treatment with upadacitinib (Rinvoq) led to greater improvements from baseline in Routine Assessment of Patient Index Data 3 (RAPID3) scores compared ...

After Rinvoq won two new indications in as many months, AbbVie's immunology compatriot Skyrizi is getting in on the approval action. Skyrizi clinched a second nod, this time to treat adults with ...

SaveHealth reports on psoriatic arthritis medications, detailing options like DMARDs, biologics, and NSAIDs, including their ...

Aug. 22, 2005 — The European Commission has approved adalimumab subcutaneous injection for the treatment of psoriatic arthritis and as first-line therapy for severe, active, and progressive rheumatoid ...

Inflammatory disorder drug developer Acelyrin has a therapeutic candidate in late-stage development in three different indications—each of them offering the biotech the chance to compete favorably ...

Share on Pinterest Humira will soon have a citrate-free biosimilar available on the market. Humira (adalimumab) is a popular medication used to treat various inflammatory conditions including ...

Alert FDA OKs Ixekizumab (Taltz) for Active Ankylosing Spondylitis The interleukin-17A inhibitor is now indicated for the treatment of adults with active ankylosing spondylitis, as well as for certain ...

Please provide your email address to receive an email when new articles are posted on . Simlandi (adalimumab-ryvk) hit the market as first interchangeable, citrate-free Humira biosimilar in a ...

When I was diagnosed with psoriatic arthritis 2 years ago at the age of 24, I almost wept with relief. For years, I’d experienced puzzling symptoms. Dark purple-brown flakes on the back of my neck and ...

Please provide your email address to receive an email when new articles are posted on . Methotrexate increases the probability of remission with adalimumab or infliximab by 50% in patients with ...

Skyrizi has demonstrated its efficacy in treating patients with psoriatic arthritis. If approved for use in the E.U., psoriatic arthritis could be a blockbuster indication for the drug. AbbVie is a ...

(Reuters) - Eli Lilly and Co said on Monday its psoriatic arthritis drug, Taltz, was found to be more effective than the world's best-selling prescription medicine, AbbVie Inc's Humira, in a ...